|
FOR IMMEDIATE RELEASE
|
DRG L1CAM ELISA kit (EIA5074) Utilized in Study of Preterm Infants |
|
Researchers at Washington University of St. Louis recently utilized DRG International’s L1CAM Elisa Kit in their study of alterations in protein regulators of neurodevelopment in the cerebrospinal fluid of infants with post-hemorrhagic hydrocephalus of prematurity. This research explored the potential diagnosis markers for this condition, in an effort to prevent premature births and compromised neurological outcomes in newborns.
Neurological outcomes of preterm infants with post-hemorrhagic hydrocephalus are among the worst in newborn medicine. There remains no consensus regarding the diagnosis or treatment of post-hemorrhagic hydrocephalus, and the pathological pathways leading to the adverse neurological sequelae are poorly understood. In the current study, we developed an innovative approach to simultaneously identify potential diagnostic markers of post-hemorrhagic hydrocephalus and investigate novel pathways of post-hemorrhagic hydrocephalus-related neurological disability.
The researchers plan to continue studying this topic, utilizing DRG’s Elisa Kits. This first study found that the late preterm period is a critical interval for neurodevelopment, and the relationship of the observed CSF protein increases to long-term developmental disability remains unclear at present. We look forward to their continued findings. |